selected publications
-
academic article
- Sulindac sulfone inhibits azoxymethane-induced colon carcinogenesis in rats without reducing prostaglandin levels. Cancer Research. 57:2909-2915. 1997
- Comparison of proliferating cell nuclear antigen (PCNA) versus the more standard measures of rectal mucosal proliferation rates in subjects with a history of colorectal cancer and normal age-matched controls. Cancer Epidemiology Biomarkers and Prevention. Prev:359-366. 1995
- Do NSAIDs exert their colon cancer chemoprevention activities through the inhibition of mucosal prostaglandin synthetase?. Journal of Cellular Biochemistry. Supp22:18-23. 1995
- Antiproliferative effect of nonsteroidal anti-inflammatory drugs against human colon cancer cells. Cancer Epidemiology Biomarkers and Prevention. 3:433-438. 1994
- Validation of proliferation indices as surrogate endpoint biomarkers. Journal of Cellular Biochemistry. 19:76-83. 1994
- Design and analysis of studies to reduce the incidence of colon polyps. Statistics in Medicine. 12:339-351. 1993
- Inhibition of prostaglandin synthesis: Potential for chemoprevention of human colon cancer. Cancer Bulletin. 43:561-568. 1992
- Piroxicam and other cyclooxygenase inhibitors: potential for cancer chemoprevention. Journal of Cellular Biochemistry. 161:156-166. 1992
-
chapter
- Arachidonic acid cascade inhibitors in chemoprevention of human colon cancer: preliminary studies. Cancer Chemoprevention. Ed. Wattenberg, L. Tokyo: CRC Press. 1992
- Reproducibility of [3h]-thymidine labeling index determinations in rectal mucosal crypt organ culture. Calcium, Vitamin D, and Prevention of Colon Cancer. Ed. Kelloff, G. Tokyo: CRC Press. 1991
- Dietary fiber of piroxicam as potential cancer prevention agents: effects on rectal epithelial cell proliferation in humans at risk of colon cancer. International Symposium on Colorectal Cancer; Hereditary Colorectal Cancer. Ed. Lynch, H T. Tokyo: Springer-Verlag. 1990